Basilea Pharmaceutica AG

SWX:BSLN Stock Report

Market Cap: CHF485.3m

Basilea Pharmaceutica Dividend

Dividend criteria checks 0/6

Basilea Pharmaceutica does not currently pay a dividend.

Key information

0%

Dividend yield

0%

Payout ratio

Industry average yield1.7%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per shareCHF0.87
Dividend yield forecast in 3Y0%

Recent dividend updates

No updates

Recent updates

Shareholders May Be More Conservative With Basilea Pharmaceutica AG's (VTX:BSLN) CEO Compensation For Now

Apr 18
Shareholders May Be More Conservative With Basilea Pharmaceutica AG's (VTX:BSLN) CEO Compensation For Now

Does Basilea Pharmaceutica (VTX:BSLN) Deserve A Spot On Your Watchlist?

Sep 20
Does Basilea Pharmaceutica (VTX:BSLN) Deserve A Spot On Your Watchlist?

Robust Earnings May Not Tell The Whole Story For Basilea Pharmaceutica (VTX:BSLN)

Feb 17
Robust Earnings May Not Tell The Whole Story For Basilea Pharmaceutica (VTX:BSLN)

Revenue Downgrade: Here's What Analysts Forecast For Basilea Pharmaceutica AG (VTX:BSLN)

Jul 01
Revenue Downgrade: Here's What Analysts Forecast For Basilea Pharmaceutica AG (VTX:BSLN)

Analysts Expect Breakeven For Basilea Pharmaceutica AG (VTX:BSLN) Before Long

Mar 24
Analysts Expect Breakeven For Basilea Pharmaceutica AG (VTX:BSLN) Before Long

If You Had Bought Basilea Pharmaceutica's (VTX:BSLN) Shares Three Years Ago You Would Be Down 19%

Feb 18
If You Had Bought Basilea Pharmaceutica's (VTX:BSLN) Shares Three Years Ago You Would Be Down 19%

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if BSLN's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if BSLN's dividend payments have been increasing.


Dividend Yield vs Market

Basilea Pharmaceutica Dividend Yield vs Market
How does BSLN dividend yield compare to the market?
SegmentDividend Yield
Company (BSLN)0%
Market Bottom 25% (CH)2.0%
Market Top 25% (CH)4.2%
Industry Average (Biotechs)1.7%
Analyst forecast in 3 Years (BSLN)0%

Notable Dividend: Unable to evaluate BSLN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate BSLN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: BSLN is not paying a notable dividend for the Swiss market.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as BSLN has not reported any payouts.


Discover strong dividend paying companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.